Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q18390439> ?p ?o }
Showing triples 1 to 27 of
27
with 100 triples per page.
- Q18390439 subject Q8760074.
- Q18390439 abstract "Rinat Neuroscience Corporation was a privately held biotechnology company that discovered and developed antibody-based drugs including: Tanezumab (codenamed RN624)., a monoclonal antibody against nerve growth factor for the treatment of pain Ponezumab (codenamed RN1219), a monoclonal antibody against Beta amyloid for the treatment of Alzheimer's disease LBR-101 (codenamed RN307), a monoclonal antibody against Calcitonin gene-related peptide for the treatment of migraines Bococizumab (codenamed RN316), a monoclonal antibody against PCSK9 designed to reduce LDL cholesterolRinat was founded in 2001 by Arnon Rosenthal and Patrick Lynn, following a broad licensing agreement with Genentech, and was acquired by Pfizer in 2006 for approximately $500M. Rinat currently operates as an independent biotechnology unit within Pfizer's Worldwide R&D group in South San Francisco".
- Q18390439 country Q30.
- Q18390439 wikiPageWikiLink Q11081.
- Q18390439 wikiPageWikiLink Q133823.
- Q18390439 wikiPageWikiLink Q14873931.
- Q18390439 wikiPageWikiLink Q206921.
- Q18390439 wikiPageWikiLink Q28749.
- Q18390439 wikiPageWikiLink Q3359612.
- Q18390439 wikiPageWikiLink Q3980782.
- Q18390439 wikiPageWikiLink Q417667.
- Q18390439 wikiPageWikiLink Q419432.
- Q18390439 wikiPageWikiLink Q422248.
- Q18390439 wikiPageWikiLink Q7227765.
- Q18390439 wikiPageWikiLink Q81938.
- Q18390439 wikiPageWikiLink Q8760074.
- Q18390439 wikiPageWikiLink Q899140.
- Q18390439 type Organization.
- Q18390439 type Agent.
- Q18390439 type Company.
- Q18390439 type Organisation.
- Q18390439 type Agent.
- Q18390439 type SocialPerson.
- Q18390439 type Thing.
- Q18390439 type Q43229.
- Q18390439 comment "Rinat Neuroscience Corporation was a privately held biotechnology company that discovered and developed antibody-based drugs including: Tanezumab (codenamed RN624)., a monoclonal antibody against nerve growth factor for the treatment of pain Ponezumab (codenamed RN1219), a monoclonal antibody against Beta amyloid for the treatment of Alzheimer's disease LBR-101 (codenamed RN307), a monoclonal antibody against Calcitonin gene-related peptide for the treatment of migraines Bococizumab (codenamed RN316), a monoclonal antibody against PCSK9 designed to reduce LDL cholesterolRinat was founded in 2001 by Arnon Rosenthal and Patrick Lynn, following a broad licensing agreement with Genentech, and was acquired by Pfizer in 2006 for approximately $500M. ".
- Q18390439 label "Rinat Neuroscience Corporation".